Saturday, April 19, 2025
Read the Digital Magazines Subscribe to the Magazines
Subscribe

Life Sciences

LINX-Watertown
Life SciencesLoansMassachusettsNortheast

Clarion Partners Receives $94M Loan for Refinancing of Metro Boston Life Sciences Facility

by Taylor Williams

WATERTOWN, MASS. — New York-based Clarion Partners has received a $94 million loan for the refinancing of LINX, a 185,015-square-foot life sciences facility in the western Boston suburb of Watertown. Completed in 2018, the two-story facility was fully leased at the time of the loan closing to three tenants: C4 Therapeutics, Addgene and Tectonic Therapeutic. Amenities include a grab-and-go café, indoor bike storage space, a locker room with showers, green space, a bocce ball court and shuttle service to Harvard Square. Riaz Cassum, Amy Lousararian and Robyn King of JLL arranged the five-year loan through European lender Société Générale on behalf of Clarion Partners.

Continue Reading
FacebookTwitterLinkedinEmail
Leasing ActivityLife SciencesMassachusettsNortheast

JLL Negotiates 60,000 SF Life Sciences Lease in Malden, Massachusetts

by Taylor Williams

MALDEN, MASS. — JLL has negotiated a 60,000-square-foot life sciences lease in Malden, a northern suburb of Boston. The tenant, locally based battery maker Alsym Energy, is relocating its headquarters from nearby Woburn to Exchange 200, a 352,000-square-foot facility that is a redevelopment of a former office building. Molly Heath, Chris McCauley and Anslee Krouch of JLL represented the landlord, a joint venture between Boston-based Berkeley Investments and Chicago-based Singerman Real Estate, in the lease negotiations. Bill Lynch and Caroline Evans of Colliers represented the tenant, which will continue operations at its Woburn facility.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentHealthcareIndianaIndustrialLife SciencesMidwestTop Stories

Eli Lilly to Build $4.5B Center for Advanced Manufacturing, Drug Development in Lebanon, Indiana

by Kristin Harlow

LEBANON, IND. — Eli Lilly and Co. (NYSE: LLY) has unveiled plans to invest $4.5 billion to create the Lilly Medicine Foundry, a new center for advanced manufacturing and drug development in Lebanon, about 27 miles northwest of Indianapolis. The Medicine Foundry, slated to open in late 2027, will be located in Indiana’s LEAP Research and Innovation District. The project brings Lilly’s total investment in the area to more than $13 billion. Earlier this year, Lilly released plans for a $5.3 billion expansion of its pharmaceutical manufacturing facility in Lebanon. “As we accelerate our work to discover new medicines for the toughest diseases, we’re continuing to invest in state-of-the-art infrastructure to support our growing pipeline,” says David Ricks, Lilly’s chair and CEO. “In addition to supplying high-quality medicine for our clinical studies, this new complex will further strengthen our process development and scale up our manufacturing capabilities to speed delivery of next-generation medicines to patients around the world.” Lilly says the flexible design of the new facility will enable production of various molecular therapies, including drug substances for small molecules, biologics and nucleic acid therapies. New technologies developed at the Medicine Foundry will be transferred to Lilly’s other manufacturing sites …

Continue Reading
FacebookTwitterLinkedinEmail
Leasing ActivityLife SciencesNortheastPennsylvania

KOKO Medical Signs 19,859 SF Life Sciences Lease in Exton, Pennsylvania

by Taylor Williams

EXTON, PA. — KOKO Medical has signed a 19,859-square-foot life sciences in Exton, a western suburb of Philadelphia. The medical device and women’s healthcare provider is relocating and expanding from nearby Malvern to the 63,000-square-foot building at 770 Pennsylvania Drive, which is part of the 800-acre Eagleview mixed-use development. Mitch Reading of Tactix Real Estate Advisors represented the tenant in the lease negotiations. Sam Sherrill represented the landlord, Hankin Group, on an internal basis.

Continue Reading
FacebookTwitterLinkedinEmail
AcquisitionsLife SciencesWashingtonWestern

Alexandria Real Estate Equities Sells Life Sciences Facility in Seattle to Fred Hutch Cancer Center for $150M

by Amy Works

SEATTLE — Alexandria Real Estate Equities, through an affiliate, has completed the sale of 1165 Eastlake Avenue East in Seattle’s Lake Union submarket to long-standing tenant Fred Hutch Cancer Center for $150 million. Alexandria developed and delivered the 100,086-square-foot, single-tenant, Class A life sciences building in 2021. Proceeds from the disposition of 1165 Eastlake will be reinvested into Alexandria’s leased development and redevelopment pipeline, which consists of research-and-development centers for top life sciences companies, including Bristol Myers Squibb and Novo Nordisk. As part of the transaction, Alexandria, through an affiliate, entered into a strategic joint venture partnership with Fred Hutch for nearby 1201 and 1208 Eastlake Avenue East, aggregating 206,031 rentable square feet, through a transfer of partial interests from the prior joint venture partner to Fred Hutch. Alexandria’s ownership interest in each 1201 and 1208 Eastlake remains unchanged at 30 percent. Fred Hutch executed early renewals at both properties, including a 15-year lease extension at 1201 Eastlake, where it occupies the entire building. These two life sciences facilities support the cancer center in its efforts to translate cancer and infectious disease discoveries into treatments and cures.

Continue Reading
FacebookTwitterLinkedinEmail
AcquisitionsLife SciencesTexas

Ascension Advisory Arranges Sale-Leaseback of 59,720 SF Life Sciences Facility in Webster, Texas

by Taylor Williams

WEBSTER, TEXAS — Ascension Advisory has arranged the sale-leaseback of a 59,720-square-foot life sciences facility in Webster, a southeastern suburb of Houston. The property was originally built in 1984. The acquisition of the facility comes as part of the buyer, mission-critical materials and chemicals manufacturer VION Biosciences, purchasing both the business operations and physical real estate of the tenant, Ansh Labs, including the Webster facility. The sales price and lease details were not disclosed.

Continue Reading
FacebookTwitterLinkedinEmail
44-Middlesex-Bedford-Massachusetts
DevelopmentIndustrialLife SciencesMassachusettsNortheast

Camber, Wheelock Complete 147,000 SF Industrial, Life Sciences Project in Bedford, Massachusetts

by Taylor Williams

BEDFORD, MASS. — A partnership between Boston-based Camber Development and Connecticut-based Wheelock Street Capital has completed a 147,000-square-foot industrial and life sciences project in Bedford, about 20 miles northwest of Boston. The project represents Phase I of a larger manufacturing campus known as 44 Middlesex, and the second phase will also center on the delivery of a 147,000-square-foot building. Construction of that facility is expected to begin in 2025 and to last about a year. Both buildings will be two-story structures and will have 105,000 square feet on the ground floor and a 42,000-square-foot mezzanine space on the second floor, as well as clear heights of 36 feet. Newmark is the leasing agent for the development.

Continue Reading
FacebookTwitterLinkedinEmail
Bedford-Labs
Life SciencesLoansMassachusettsNortheast

JLL Arranges $150M Loan for Refinancing of Metro Boston Life Sciences Facility

by Taylor Williams

BEDFORD, MASS. — JLL has arranged a $150 million loan for the refinancing of Bedford Labs, a 288,000-square-foot life sciences facility located about 20 miles northwest of Boston. Bedford Labs, which sits on a 52-acre site that can support up to 300,000 square feet of new construction, is a redevelopment of a former single-tenant office building. The facility includes a 28,000-square-foot amenity space and was fully leased to biotechnology firm Sarepta Therapeutics at the time of the loan closing. Brett Paulsrud, Tom Sullivan and Mike Shepard of JLL arranged the loan through an affiliate of Apollo Global Management. The borrower is a partnership between AEW Capital Management, Redgate and Optimum Asset Management.

Continue Reading
FacebookTwitterLinkedinEmail
DevelopmentLife SciencesTexasTop Stories

City of Plano Approves $4B Texas Research Quarter Life Sciences Project

by Kristin Harlow

PLANO, TEXAS — The Plano City Council has approved a development agreement to support the Texas Research Quarter (TRQ), a life sciences-focused innovation district. The first phase would involve redevelopment and new construction at the former Electronic Data Systems (EDS) headquarters, a 91-acre site that serves as the TRQ main campus. Plano is located approximately 20 miles north of Dallas. The development agreement provides reimbursement to incentivize investment and development within a newly created tax-increment reinvestment zone (TIRZ), which contains the TRQ properties and other parts of Plano’s Legacy neighborhood. Total project costs are estimated at $4 billion, according to the Dallas Business Journal. Future phases include additional redevelopment activity across the main campus, as well as the creation of an integrated multi-site district through development at adjacent and nearby properties. Dallas-based NexPoint, an alternative investment manager with a real estate arm, is spearheading the development. “The city council approval is just the first step in a comprehensive plan to develop the TRQ into a world-class hub for life sciences,” says Eric Danielson, managing director and head of real estate development at NexPoint. “We are committed to collaborating with the community to build a dynamic ecosystem that will drive innovation, …

Continue Reading
FacebookTwitterLinkedinEmail
Leasing ActivityLife SciencesNortheastPennsylvania

Frontage Laboratories Inks 46,300 SF Life Sciences Lease Expansion in Exton, Pennsylvania

by Taylor Williams

EXTON, PA. — Locally based pharmaceutical development company Frontage Laboratories has inked a 46,300-square-foot life sciences lease expansion in Exton, a western suburb of Philadelphia. Frontage Labs joins Switzerland-based Fruh Packaging to bring occupancy of the new, 113,000-square-foot building at 240 Sierra Drive to 100 percent. Frontage’s total footprint in Exton now spans about 200,000 square feet, and the expansion is expected to create about 100 new employment opportunities. No third-party brokers were involved in the lease negotiations.

Continue Reading
FacebookTwitterLinkedinEmail
Newer Posts
Older Posts